Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
55.38B | 39.73B | 29.55B | 30.29B | 35.45B | Gross Profit |
4.23B | 3.99B | 4.88B | 3.72B | 3.04B | EBIT |
722.00M | 315.00M | 1.51B | 456.00M | 55.00M | EBITDA |
2.29B | 1.23B | 2.38B | 1.41B | 668.00M | Net Income Common Stockholders |
625.00M | 328.00M | 1.34B | 776.00M | -317.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.59B | 7.88B | 12.34B | 8.93B | 8.64B | Total Assets |
76.83B | 61.13B | 52.53B | 49.94B | 50.75B | Total Debt |
21.28B | 12.22B | 9.00B | 9.97B | 10.09B | Net Debt |
14.69B | 4.34B | -3.34B | 1.04B | 1.46B | Total Liabilities |
43.76B | 31.27B | 22.98B | 21.91B | 24.15B | Stockholders Equity |
32.53B | 29.38B | 29.12B | 27.69B | 26.60B |
Cash Flow | Free Cash Flow | |||
-9.72B | -7.60B | 4.61B | 2.70B | -2.73B | Operating Cash Flow |
-8.58B | -6.50B | 4.82B | 3.49B | -2.28B | Investing Cash Flow |
-146.00M | -643.00M | 37.00M | -2.52B | -426.00M | Financing Cash Flow |
7.43B | 2.68B | -1.45B | -686.00M | -521.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $1.66T | 14.40 | 9.52% | 2.67% | 2.43% | 7.98% | |
67 Neutral | ¥29.76B | 16.41 | 2.89% | 6.92% | -23.35% | ||
67 Neutral | ¥7.28B | 6.89 | 4.48% | -15.81% | 22.97% | ||
64 Neutral | $1.59T | 12.88 | 10.95% | 3.47% | 11.60% | 79.43% | |
64 Neutral | $4.27B | 11.81 | 5.31% | 249.66% | 4.08% | -8.61% | |
61 Neutral | ¥1.39T | 13.37 | 11.76% | 2.63% | 27.41% | 214.53% | |
48 Neutral | €78.46B | ― | -12.02% | 2.93% | -1.81% | 61.42% |